Search references for CDKN2A. Phrases containing CDKN2A
See searches and references containing CDKN2A!CDKN2A
Protein-coding gene in humans
CDKN2A, also known as cyclin-dependent kinase inhibitor 2A, is a gene which in humans is located at chromosome 9, band p21.3. It is ubiquitously expressed
CDKN2A
Medical condition
inherited in an autosomal dominant pattern, and caused by mutations in the CDKN2A gene. In addition to melanoma, individuals with the condition are at increased
Dysplastic_nevus_syndrome
Mammalian protein found in humans
p16 (also known as p16INK4a, cyclin-dependent kinase inhibitor 2A, CDKN2A, multiple tumor suppressor 1 and numerous other synonyms), is a protein that
P16
Interruption of cardiac blood supply
with chromosome 9 on the short arm p at locus 21, which contains genes CDKN2A and 2B, although the single nucleotide polymorphisms that are implicated
Myocardial_infarction
Skin cancer originating in melanocytes
transmitted autosomal dominantly and mostly associated with the CDKN2A mutations. People who have a CDKN2A mutation associated with FAMMM have a 38-fold increased
Melanoma
Type of endocrine gland cancer
multiple mole and melanoma syndrome, FAMMM-PC) due to mutations in the CDKN2A tumor suppressor gene; autosomal recessive ATM and autosomal dominantly
Pancreatic_cancer
Type of brain cancer
microvascular proliferation and necrosis (features that, along with homozygous CDKN2A/B deletion, define grade 4) The MIB-1 (Ki-67) labelling index is usually
Anaplastic_astrocytoma
Pharynx cancer that is located in the oropharynx
Asbestos-related diseases); Certain genetic changes including: P53 mutation and CDKN2A (p16) mutations; Poor nutrition; Plummer–Vinson syndrome. Erythroplakia;
Oropharyngeal_cancer
Uterine cancer that is located in tissues lining the uterus
point mutation unknown 17–41% CDH1 loss of heterozygosity unknown 80–90% CDKN2A loss of heterozygosity or epigenetic silencing 20% 40% PIK3CA (oncogene)
Endometrial_cancer
Human protein
suppressor, ARF, p14ARF) is an alternate reading frame protein product of the CDKN2A locus (i.e. INK4a/ARF locus). p14ARF is induced in response to elevated
P14arf
Type of spinal cancer
respectively. The CDKN2A (p16) and CDKN2B (p15) loci on chromosome 9p21 are frequently deleted in chordomas Another study found CDKN2A immunoreactivity
Chordoma
Precancerous tissue formation in the esophagus
Maley CC, Sanchez CA, Odze RD, et al. (February 2007). "NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma"
Barrett's_esophagus
Tumor or other abnormal growth of tissue
Kolios G (July 2010). "Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas". World J. Gastroenterol. 16 (28): 3553–60. doi:10
Neoplasm
Swiss breed of dog
role in this are mutations to genes that help suppress tumours, including: CDKN2A/B, PTEN, and RB1. Another related mutation is to the PTPN11 gene, which
Bernese_Mountain_Dog
identified four mutations located in or around the tumor suppressor locus CDKN2A, which appear to be associated with sex-linked barring. The four mutations
Sex-linked_barring
Cancer originating in or on the ovary
CCND2 upregulation 15% CCNE1 amplification 20% CDK12 high-grade serous CDKN2A downregulation (30%) and deletion (2%) 32% CTNNB1 clear-cell DICER1 missense
Ovarian_cancer
Cell lineage used in cell cultures
the type I interferon gene cluster and cyclin-dependent kinase inhibitors CDKN2A and CDKN2B in the genome. Although African green monkeys were previously
Vero_cell
Online biology database
(tissue) summary page provides lists of mutated genes. The figure shows the CDKN2A gene, which is a tumor suppressor that leads to cancer when it is inactivated
COSMIC_cancer_database
Type of brain tumor
volume, or increased cerebrospinal fluid volume. Homozygous deletion of CDKN2A/B is the main feature of high grade astrocytoma. In addition, a genome-wide
Astrocytoma
Medical condition
observed in tumor suppressors such as CDKN2A, PTEN and NF1. Some alterations such as the ones affecting TP53 and CDKN2A are shared by lung SCC and the other
Squamous-cell carcinoma of the lung
Squamous-cell_carcinoma_of_the_lung
Mole in the skin with an abnormal appearance
40-50% of cases, the disorder has been linked with germline mutations in the CDKN2A gene, which codes for p16 (a regulator of cell division). Low magnification
Dysplastic_nevus
Blood cancer characterized by overproduction of lymphoblasts
more mutations. Common inherited risk factors include mutations in ARID5B, CDKN2A/2B, CEBPE, IKZF1, GATA3, PIP4K2A and, more rarely, TP53. These genes play
Acute_lymphoblastic_leukemia
Type of acute lymphoblastic leukemia
but specific genetic mutations (commonly including those in NOTCH1 and CDKN2A) may be passed along, increasing susceptibility to cases of T-ALL. Some
T-cell acute lymphoblastic leukemia
T-cell_acute_lymphoblastic_leukemia
Anti-breast cancer medication
20 July 2023. "Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6". www.clinicaltrials.gov. Retrieved
Abemaciclib
Project to catalogue genetic mutations responsible for cancer
heterogeneous, with alterations to CDKN2A, SETD2, TFE3, or increased expression of the NRF2–ARE pathway; loss of expression of CDKN2A and CpG island methylation
The_Cancer_Genome_Atlas
Cellular mechanism
K, et al. (July 2010). "Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas". World Journal of Gastroenterology. 16 (28):
DNA_repair
Medical condition
Unlike some malignant mesotheliomas, adenomatoid tumors do not harbor CDKN2A deleterious mutations. In order to see adenomatoid tumors multiple imaging
Adenomatoid_tumor
American cancer researcher (born 1966)
Kingsmore, D; Stevenson, KS; Koppelstaetter, C; et al. (2013). "Pre-Transplant CDKN2A Expression in Kidney Biopsies Predicts Renal Function and Is a Future Component
Norman_Sharpless
Medical condition
have or do not have, respectively, inactivating mutations in both of their CDKN2A genes. Magro CM, Porcu P, Ahmad N, Klinger D, Crowson AN, Nuovo G (September
Cutaneous_B-cell_lymphoma
Medical condition
beta-2-microglobulin levels; CLL/SLL cells which develop deletions in the CDKN2A gene, disruptions of the TP53 gene, activation of the C-MYC gene, trisomy
Richter's_transformation
Genes such as CDKN2A, CDKN2B, and HNF1B exhibit increase the risk phenotype with SNPs in their 3' UTR miRNA binding sites. As CDKN2A and B regulate the
Genetic causes of type 2 diabetes
Genetic_causes_of_type_2_diabetes
FiercePharma. 7 December 2020. Retrieved 2021-10-01. "Dual Targeting of CDKN2A and PIK3CA May Offer Better Outcomes in Urothelial Carcinoma". Targeted
List of Johnson & Johnson products and services
List_of_Johnson_&_Johnson_products_and_services
Health issue in Japan
allelic frequencies between these populations. Genes such as CDKAL1, IGF2BP2, CDKN2A/CDKN2B, HHEX, SLC30A8, and KCNJ11 have shown risk alleles persistent to
Diabetes_in_Japan
Indian-American biostatistician, data scientist
; DeLancey, J. O.; Raskin, L. (2012). "Risk of Non-Melanoma Cancers in CDKN2A Mutation Carriers". Journal of the National Cancer Institute. 104 (12):
Bhramar_Mukherjee
Genetically inherited cancer of certain nerve tissues
primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene". BMC Genomics. 9: 353. doi:10.1186/1471-2164-9-353. PMC 2527340. PMID 18664255
Neuroblastoma
Cancer of the throat
the pRb pathway is inactivated by E7 instead of Cyclin D1 amplification. CDKN2A is a tumour suppressor gene that encodes a tumor suppressor protein, p16
HPV-positive oropharyngeal cancer
HPV-positive_oropharyngeal_cancer
Cancer arises in the head or neck region
patterns. In HPV-negative disease, genes frequently mutated include TP53, CDKN2A and PIK3CA. In HPV-positive disease, these genes are less frequently mutated
Head_and_neck_cancer
Protein-coding gene in humans
CDKN2B gene in humans. This gene lies adjacent to the tumor suppressor gene CDKN2A in a region that is frequently mutated, deleted, or disregulated in a wide
CDKN2B
Non-coding RNA in humans
spliced product is a 3834bp RNA. It is located within the p15/CDKN2B-p16/CDKN2A-p14/ARF gene cluster, in the antisense direction. Single nucleotide polymorphisms
CDKN2BAS
Medical condition
neoplastic cells in PT-DLBCL have deletions in one or both copies of the CDKN2A gene which can lead to genome instability, i.e. a high rate of acquisition
Primary testicular diffuse large B-cell lymphoma
Primary_testicular_diffuse_large_B-cell_lymphoma
Human protein
as well as in its related proteins including D-type cyclins, p16(INK4a), CDKN2A and Rb were all found to be associated with tumorigenesis of a variety of
Cyclin-dependent_kinase_4
1951 mouse tumour still used in research
present in 30 cancer genes including Kras, Nras, Trp53, Dcc, and Cacna1d. Cdkn2a and Cdkn2b are biallelically deleted from the genome. Five pathways (RTK/RAS
Lewis_lung_carcinoma
Cancer of the adrenal cortex
and DAXX. The telomerase gene TERT is often amplified while ZNRF3 and CDKN2A are often homozygously deleted. The genes h19, insulin-like growth factor
Adrenocortical_carcinoma
Mammalian protein found in Homo sapiens
Seferiadis K, et al. (2010). "Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas". World Journal of Gastroenterology. 16 (28):
Methylated-DNA–protein-cysteine methyltransferase
Methylated-DNA–protein-cysteine_methyltransferase
Form of cancer
Glendening, J.M., Flores, J.F., Walker, G.J., et al. 1997. "Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation
Epigenetics_and_melanoma
Medical condition
pathways, which includes CDKN2A silencing, mutation in chromatin-modifying genes, and a GpG island methylator phenotype (CIMP). CDKN2A is a tumor suppressor
Papillary renal cell carcinoma
Papillary_renal_cell_carcinoma
Protein which inhibits cyclin-dependent kinase
Protein Gene Target p16 CDKN2A Cyclin-dependent kinase 4, Cyclin-dependent kinase 6 p15 CDKN2B Cyclin-dependent kinase 4 p18 CDKN2C Cyclin-dependent kinase
Cyclin-dependent kinase inhibitor protein
Cyclin-dependent_kinase_inhibitor_protein
Study of how diet changes gene expression
(2020-06-01). "Genistein inhibited the proliferation of kidney cancer cells via CDKN2a hypomethylation: role of abnormal apoptosis". International Urology and
Nutritional_epigenetics
Lung cancer of glandular origin or characteristics
have been reported, as well as deletions of tumor suppressor genes such as CDKN2A. Frequent alterations occur in genes belonging to the receptor tyrosine
Adenocarcinoma_of_the_lung
Cancer originating in lymph nodes
function-associated antigen 3, that is involved in activating T-cells), CDKN2A (encoding p16INK4a and p14arf tumor suppressor proteins) or CDKN2B (encoding
Follicular_lymphoma
Mouse myoblast cell line
this in C2C12 skeletal muscle cells is believed to be in the INK4a gene (CDKN2A). Electrical pulse stimulation (EPS) is an in vitro method used to mimic
C2C12
Hemochromatosis C7orf11 Trichothiodystrophy CBS Cystathionine synthase Homocystinuria CDKN2A Familial melanoma syndrome CHS1 (LYST) Chédiak–Higashi syndrome CXCR4 WHIM
List of genes mutated in cutaneous conditions
List_of_genes_mutated_in_cutaneous_conditions
Protein-coding gene in the species Homo sapiens
and localize to actin stress fibers. STK35L1 regulates the expression of CDKN2A and inhibiting G1- to S-phase transition. Depletion of STK35L1 by siRNA
STK35L1
Protein-coding gene in humans
Moretti A, Basso G, Borriello A, Della Ragione F (1998). "Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma". Hepatology
CDKN2C
Type of poultry breed
Leif Andersson (2010). Sex-linked barring in chickens is controlled by the CDKN2A/B tumour suppressor locus. Pigment Cell and Melanoma Research. 23 (4): 521–530
Auto-sexing
Benign nerve-sheath tumor in the peripheral nervous system
cancers from neurofibromas is associated with the loss of expression of the CDKN2A or TP53 gene in nonmyelinating Schwann cells that also exhibit biallelic
Neurofibroma
Laboratory assessment of re-epithelialization in cell cultures
Iwei; Bastian, Boris C.; Judson, Robert L. (July 2018). "Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation". Cancer Cell. 34 (1): 56–68
Wound_healing_assay
P38936 2673 CDKN1B HGNC:1785; P46527 2674 CDKN1C HGNC:1786; P49918 2675 CDKN2A HGNC:1787; P42771, Q8N726 2676 CDKN2AIP HGNC:24325; Q9NXV6 2677 CDKN2AIPNL
List of human protein-coding genes 2
List_of_human_protein-coding_genes_2
Single stranded RNA
induce DNA methylation, can also repress the neighboring gene of CDKN2B, CDKN2A, by recruiting polycomb repressive complex 2 (PRC2) which leads to histone
Antisense_RNA
American oncologist
TP53 and CDKN2A in order to show that patterns of hotspot mutations in TP53 differed depending on the presence or absence of a co-occurring CDKN2A mutation
Erica_Golemis
Enzymes responsible for polyamine metabolism
"Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line". Cancer Research
MTAP
Medical condition
Linda; Sini, Maria C.; Palmieri, Giuseppe; Scarrà, Giovanna Bianchi (2009). "CDKN2A and MC1R analysis in amelanotic and pigmented melanoma". Melanoma Research
Amelanotic_melanoma
Human disease (cancer)
potential responsiveness to immunotherapy. The C3 subtype, with frequent CDKN2A aberrations, could benefit from a combination of KIT and CDK4/6 inhibitors
Gastrointestinal stromal tumor
Gastrointestinal_stromal_tumor
Medical condition
Hypermethylated of the promoters for two tumor suppressor genes, CDKN2B and CDKN2A (11 and 44% of cases, respectively) stops the genes from expressing their
Primary cutaneous diffuse large B-cell lymphoma, leg type
Primary_cutaneous_diffuse_large_B-cell_lymphoma,_leg_type
Protein-coding gene in the species Homo sapiens
and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations". Fam. Cancer. 9 (4): 625–33. doi:10.1007/s10689-010-9356-3. PMC 3233727
IFNA16
Medical condition
chromosomes 9. This results in a loss of heterozygosity for two genes, the CDKN2A gene which encodes cyclin-dependent kinase Inhibitor 2A, a protein that
Monomorphic epitheliotropic intestinal T cell lymphoma
Monomorphic_epitheliotropic_intestinal_T_cell_lymphoma
homolog of p53, and deletion of the p53 pathway gene p14arf/p16/INK4A (CDKN2A) have also been found in pediatric ependymomas. Over-expression of components
Pediatric_ependymoma
Field of study
genes frequently observed are APC, CDH1, CDKN2A, MGMT, and RASSF1A (a tumor suppressor). In the cases of CDKN2A and RASSF1A DNA these genes are methylated
Pharmacoepigenetics
Medical condition
the disease: 1) mutations in NRAS, ASXL1, and TP53; 2) deletions of the CDKN2A-ARF-CDKN2B locus on the short arm of chromosome 9, CDKN1B locus on the short
Blastic plasmacytoid dendritic cell neoplasm
Blastic_plasmacytoid_dendritic_cell_neoplasm
Susceptibility of cells to radiation
with radiosensitivity in normal tissues: γH2AX, TP53BP1, VEGFA, CASP3, CDKN2A, IL6, and IL1B. Stochastic effects do not have a threshold of irradiation
Radiosensitivity
Short RNA molecule
Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S (July 2009). "CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant
Mir-423 microRNA precursor family
Mir-423_microRNA_precursor_family
Mammalian protein found in Homo sapiens
A, Franco MF, Esteves EB, Scherrer L, Gallo CV, et al. (October 2015). "CDKN2A (p14(ARF)/p16(INK4a)) and ATM promoter methylation in patients with impalpable
ATM_serine/threonine_kinase
Medical condition
deletions in the NF1 gene occur ~10% of MFS cases while mutations in the CDKN2A/CDKN2B and amplifications in the CDK6, CCND1, and MDM2 genes occur in rare
Myxofibrosarcoma
Protein domain
BAT8; BCL3; BCOR; BCORL1; BTBD11; CAMTA1; CAMTA2; CASKIN1; CASKIN2; CCM1; CDKN2A; CDKN2B; CDKN2C; CDKN2D; CENTB1; CENTB2; CENTB5; CENTG1; CENTG2; CENTG3;
Ankyrin_repeat
Protein-coding gene in humans
Kashiwagi A, Kaku K, et al. (March 2008). "Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a
CDKAL1
Field of study in cancer research
genes are epigenetically altered in sarcomas. These include APC, CDKN1A, CDKN2A, CDKN2B, Ezrin, FGFR1, GADD45A, MGMT, STK3, STK4, PTEN, RASSF1A, WIF1, as
Cancer_epigenetics
Protein-coding gene in the species Homo sapiens
Tanzawa H (June 2003). "Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity".
DNA (cytosine-5)-methyltransferase 3A
DNA_(cytosine-5)-methyltransferase_3A
Protein-coding gene in humans
gov. Retrieved 2016-05-10. "www.genecards.org/cgi-bin/carddisp.pl?gene=CDKN2A". www.genecards.org. Retrieved 2016-05-10. "www.genecards.org/cgi-bin/carddisp
CCDC180
Human protein
ER (2008). "BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression". Cancer Res. 68 (16): 6507–15. doi:10.1158/0008-5472.CAN-07-6152
BMI1
Protein-coding gene in humans
(mouse) or the human equivalent p14ARF, which are alternative products of the CDKN2A gene. GRCh38: Ensembl release 89: ENSG00000129355 – Ensembl, May 2017 GRCm38:
CDKN2D
Protein-coding gene in the species Homo sapiens
of target genes, including mitochondrial fission process 1 (MTFP1) and CDKN2A. ZBTB48 localizes to chromosome 1p36, a region that is frequently rearranged
ZBTB48
Complication of celiac disease
on the short or "p" arm of chromosome 17; genomic alterations around the CDKN2A tumor suppressor and CDKN2B cell proliferation regulator at position p21
Enteropathy-associated T-cell lymphoma
Enteropathy-associated_T-cell_lymphoma
cyclin-dependent kinase inhibitor 2A (CDKN2A), a negative regulator of the cell cycle. On the other hand, downregulation of CDKN2A correlates with chronic neurological
MiR-125
of CNS relapse. ABC subtype DLBCL, characterized by gene alterations (at CDKN2A) affecting NF-κB signaling, is associated with worse survival outcomes and
Central nervous system prophylaxis
Central_nervous_system_prophylaxis
Protein-coding gene in the species Homo sapiens
of EZH2-mediated transcriptional repression include HOXA9, HOXC8, MYT1, CDKN2A and retinoic acid target genes. In cancer, EZH2 may play a role in activation
EZH2
RNA molecule
Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S (July 2009). "CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant
Mir-584 microRNA precursor family
Mir-584_microRNA_precursor_family
Biochemical changes to RNA
regulation of tumor suppressors like cyclin-dependent kinase inhibitor 2A (CDKN2A) and breast cancer 2 (BRCA2). On the other hand, increased m6A levels inhibit
Epitranscriptome
Protein-coding gene
and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations". Familial Cancer. 9 (4): 625–633. doi:10.1007/s10689-010-9356-3
IFNK
the University of Rochester Medical Center identify four genes – KRAS, CDKN2A, SMAD4, and TP53 – responsible for how long patients survive with pancreatic
2017_in_science
Accumulation of mutations
confirmed although mutations in some tumor suppressor genes, including CDKN2A (p16), predispose to clonal expansions that encompass large numbers of crypts
Somatic_evolution_in_cancer
Use of epigenome-influencing techniques to treat medical conditions
tumor-suppressor genes which can cause transcriptional inactivation of genes (i.e. CDKN2A) encoding for other regulatory proteins (i.e. p14 and p16) that play a vital
Epigenetic_therapy
Medical condition
in a single case, and, in individual cases, mutations in the TP53, RB1, CDKN2A and HRAS tumor suppressor genes. Further studies are needed to determine
Porocarcinoma
Precursor microRNA family
Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S (July 2009). "CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant
Mir-32 microRNA precursor family
Mir-32_microRNA_precursor_family
Protein-coding gene in the species Homo sapiens
Sato N, Sawabe M, Muramatsu M (2014-01-01). "Associations between the CDKN2A/B, ADTRP and PDGFD polymorphisms and the development of coronary atherosclerosis
HHIPL1
RNA family
M.; Salmenkivi, K.; Bagwan, I.; Nicholson, A. G.; Knuutila, S. (2009). "CDKN2A,NF2, andJUNare dysregulated among other genes by miRNAs in malignant mesothelioma-A
Mir-885 microRNA precursor family
Mir-885_microRNA_precursor_family
neural system tumor syndrome; 155755; CDKN2A Melanoma; 609048; CDK4 Melanoma, cutaneous malignant, 2; 155601; CDKN2A Meleda disease; 248300; SLURP1 Melnick–Needles
List_of_OMIM_disorder_codes
RNA family
Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S (July 2009). "CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant
Mir-455 microRNA precursor family
Mir-455_microRNA_precursor_family
Type of modification to a cell's epigenome
successful. The epigenetic intervention was fruitful in demethylating loci (i.e. CDKN2A, ESR1, HPP1, MGMT, TIMP3) abnormally methylated in gastric carcinomas. A
Epigenetic_priming
RNA family
Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S (July 2009). "CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant
Mir-340 microRNA precursor family
Mir-340_microRNA_precursor_family
Digital information reflecting an individual's karyotype
(acquired uniparental disomy) has been reported at key loci in ALL, such as CDKN2A gene at 9p, which have prognostic significance. SNP array virtual karyotyping
Virtual_karyotype
CDKN2A
CDKN2A
CDKN2A
CDKN2A
Girl/Female
Hindu, Indian, Kannada, Malayalam, Marathi, Sanskrit, Tamil, Telugu
Wise; Intelligent
Surname or Lastname
English
English : nickname for someone thought to resemble a woodpecker in some way, Middle English spek(e) (a reduced form of Old French espeche(e), of Germanic origin).
Girl/Female
Muslim
Best of women epithet of kh
Boy/Male
Arabic, Muslim
Hardworker
Boy/Male
Russian
Worships God.
Girl/Female
Hindu
Little gift, End less
Female
Irish
Irish name AGHADREENA means "from the field of the sloe bushes."
Boy/Male
Christian & English(British/American/Australian)
Beyond Praise
Girl/Female
Hindu, Indian, Kannada, Malayalam, Marathi, Sanskrit, Sindhi, Tamil, Telugu
Goddess Lakshmi
Female
Hindi/Indian
(लीला) Hindi name LEELA means "play."
CDKN2A
CDKN2A
CDKN2A
CDKN2A
CDKN2A